• 제목/요약/키워드: U-Health Care framework

검색결과 15건 처리시간 0.021초

자궁적출술 환자를 위한 critical pathway 개발과 적용효과 (Critical Pathway Development for the Hysterectomy Patients and its applied Effect)

  • 노기옥;박경숙
    • 여성건강간호학회지
    • /
    • 제6권2호
    • /
    • pp.234-257
    • /
    • 2000
  • At present in the medical care, the study and effort for producing health service to consider efficiency, effectiveness, and quality are urgently called for because of the difficulty in the keen competition according to the inter- nationalization and opening, the operation in the medical institution service testing system, the change in the medical policy of KDRGs, and the lack of the health care cost increasing rate. As an alternative, the case management for the new management system is introduced in the U.S., and the Critical Pathway that is the method designing the contents of activity and its result has been developed and applied in order to anticipate and manage the patient-outcome for the realization of the cost-effective case-management. Thus, this study intended to analyze the effectiveness to obtain by developing the Critical Pathway presented as the method to improve the quality-betterment and cost effectiveness through the continuous and consistent patient management for the hysterectomy patient and applying it to the real practice. As a study method, this author formed a conceptual framework through considering five Critical Pathway used in the current U.S. and three Critical Pathway presented in the literature to develop the Critical Pathway for the hysterectomy patient, and made out the preliminary Critical Pathway through reviewing the old chart. This author made the verified the validity of the expert group about the developed Critical Pathway, and to confirm the possibility of practice application, completed and settled the final Critical Pathway after using the Critical Pathway to the hysterectomy patient from March 1st to 15th, 1997. Finally, to analyze the application-effect of the developed Critical Pathway, this author offered health care service applying the Critical Pathway to the hysterectomy patient from April 15th to August 31th, 1997. The guide for the Critical Pathway was carried out in advance by outpatient setting nurse for outpatient setting visit before the operation, and after hospitalization the primary nurse monitored the execution degree on the every duty. After discharge this author surveyed the complication through phone visiting, and one month after discharge surveyed the patient's reaction about the offered service when outpatient setting visit and analyzed the result. The source for health care cost was obtained by the statistics about the hospital charge which was offered by the General Business Department. The results were as follows. 1. It was decided that the vertical line of the Critical Pathway was made up of eight items such as monitoring/assessment, treatment, line/drains, activity, medication, lab test, diet, patient teaching, and the horizontal line of the Critical Pathway was made up of from hospitalization to discharge. 2. After the analysis of service contents through reviewing the old chart, it was decided that the horizontal line of the preliminary Critical Pathway was made up of from hopitalization to fourth postoperative day, and the vertical line of it was divided into eight items which were the contents to occur with the time frame of the horizontal line. 3. After the verifying the validity of the expert group about the preliminary Critical Pathway, the horizontal line was amended from hopitalization to third postoperative day, and taking their consensus, some contents of the horizontal line was amended and deleted. 4. From March 1st to 15th, 1997, to confirm the clinical suitability, this author offered eight hysterectomy patients the medical service through the Critical Pathway. The result was that three of them could be discharged at the expected discharge day, and the others later than that day. Supplementing the preliminary Critical Pathway through analyzing the cause of that delay- case, this author developed the final Critical Pathway. 5. There were no significant differences between the experimental and the control group in the incidence of complication(P > 0.05). 6. The 92.4% of experimental group was satisfied with the Critical Pathway service. 7. The length of hospital stay of the experimental group offered with the Critical Pathway service was 4.6 days and there was a significant difference that it was 1.3 days shorter than that of the control group(t=-29.514, P=0.000). 8. There wsa a significant difference that the mean medical charge per one patient of the experimental group offered the Critical Pathway service was cheaper \124,150 than that of the control group(t=-9.826, P=0.000). 9. The result that the author assumed and analyzed hospital income with the rate of turning bed was assumed that the increase of hospital income was \63,245,072 for that study, and the income increase was expected with \68,704,864 for a year. The result that this author applied the Critical Pathway to the hysterectomy patient have no differences in the incidence of complication, high satisfaction with that service, and the length of hospital stay decreased in the experimental group, and the mean hospital charge per one patient decreased, but hospital income increased. Suggestions for further study and nursing practice are as follows. 1. The study to apply the Critical Pathway for a year, verify the validity, and measure the effect repeatedly is needed. 2. To apply and manage the Critical Pathway effectively, the study to computerize it is needed. 3. The study to develop hospital-based Critical Pathway about other diseases or procedure, and measure the effect is needed.

  • PDF

유전상담 교육프로그램 개발과 전문유전상담사 학회인증제도에 관한 연구 (A Study on Genetic Counseling Curriculum, Accreditation of the Training Program, and the Certification Process of Genetic Counselors in Korea)

  • 최지영;김현주
    • Journal of Genetic Medicine
    • /
    • 제6권1호
    • /
    • pp.38-55
    • /
    • 2009
  • 목 적: 국내실정에 맞는 전문 유전상담사 교육프로그램과 교육기관의 인정 및 유전상담사의 전문 자격 인증 제도를 설립에 근거자료로 활용하고자 하였다. 대상 및 방법: 국외의 유전상담사 교육 프로그램 인정과 유전상담사 인증 제도를 파악하고, 관련 업무 종사자에게 설문조사를 실시하였으며, 전문가 회의를 통해 도출된 의견을 분석하였다. 결 과: 인정받은 교육기관 수료자만을 인증시험요건으로 규정한 미국과는 달리, 일본은 관련 분야의 임상경력을 갖춘자에게도 한시적으로 인증시험 자격을 부여하였다. 일본은 필기와 면접시험으로, 미국은 필기시험으로 인증 시험이 진행되고 있으며, 주기는 미국 2년, 일본 1년, 인증기간은 미국 10년, 일본 5년이었다. 설문조사에서는 '대한의학유전학회에서 위원회를 구성하여 교육기관 인정과 전문 유전상담사 인증을 담당하며, 관련학회의 의견수렴과 자문을 얻는다'에 대다수가 찬성하였다. 지원자의 전공은 제한할 필요가 없으며, 인증시험은 필기와 실기로 이루어져야하고 주기는 2년, 인증기간은 5년이 적당하다는 응답이 가장 많았다. 결 론: 유전상담 교육기관 및 유전상담사 인증 제도는 대한 의학유전학회에서 주관하며, 미국과 일본의 프로그램을 참고하여 국내실정에 맞게 도입한다. 대한의학유전학회에서는 위원회를 구성하여 관련 학회 등의 의견수렴과 자문을 얻어 교육프로그램 개발과 인증 제도를 구체화 할 것을 촉구하는 동시에 정부에서도 유전상담의 급여화와 필요한 제도적인 지원이 있어야만 국내의 유전의료의 발전에 필요한 인프라 구축의 내실을 다질 수 있게 될 것이다.

  • PDF

제왕절개술 환자를 위한 Critical Pathway 개발 (Development of the Critical Pathway for Cesarean Section Patient)

  • 정경희;장금성
    • 한국간호교육학회지
    • /
    • 제4권1호
    • /
    • pp.66-80
    • /
    • 1998
  • With the opening of healthcare market, the health care environment in Korea is anticipating a drastic change. In this Internationally open market environment, it is necessary to introduce a systematic health care plan and DRG system which offer qualitative medical services as well as reduced cost. Purpose of this study is to develop and test the critical pathway for Cesarean section patient in the way to be possible the integrated inpatient management. It was adopted the process of six phases to develop the critical pathway as the theoretical framework implemented by Johns Hopkins Hospital, Maryland, U.S.A. In the first phase, make a selection of diagnosis/procedures to develop. In the second phase, organize a development team consisted of eight expertises working in maternity nursing area. In the third phase, analyze the overall medical service offered to patient through review medical records and decided the service content and the implementation period for the Cesarean section patient. In the forth phase, make out a preliminary critical pathway after verification of expert group on content validity. In the fifth phase, validity operate to ten Cesarean section patients to test implementation in practice by using the preliminary critical pathway, In the sixth phase, defined the final critical pathway. The result of this study was as follows. 1. There were classified 8 categories as monitoring/assesment, treatment, medication, activity, diet, test, consult, education/discharge plan for vertical axis and showed hospital stayed from admission to discharge for horizontal axis of critical pathway through analysis 68 Cesarean section patients medical records. 2. After critical review 68 medical records to make out a preliminary critical pathway, hospital stays for horizontal axis were showed 6 days, mean hospital stays were 7.5 days, 2.1 days were to be taken operation after admission and 4.2 days were stayed until discharge after operation. 3. After making out a questionare in 90 items of a medical service content of eight categories and verifying the content validity of expertises, the 85 items of the preliminary critical pathway were selected by expertises agreement over 88% and modified or deleted 5 items showing agreement below 75%. 4. After verifying a validity to 10 patients for 4 weeks, hospital stays were 5.9 days. There were deleted 1 item and modified or supplemented the 9 items of the 10 items.

  • PDF

국내 관상동맥질환자의 이차예방을 위한 "이행" 관련 논문분석 (Analysis of Research on Adherence for Secondary Prevention in Patients with Coronary Artery Disease in Korea)

  • 손연정;김선희;송효숙
    • 기본간호학회지
    • /
    • 제17권4호
    • /
    • pp.575-587
    • /
    • 2010
  • Purpose: The purpose of this study was to analyze the research on adherence for secondary prevention in patients with coronary artery disease (CAD) in Korea, and to identify the strategies for improvement that should be included in future studies. Methods: Electric literature searches were conducted for Pubmed, CINAHL, RISS4U, KISTI, DBpia, KoreaMed, National Assembly Library, and National Library of Korea. A total of forty two articles published between 1986 and 2009 were selected based on established inclusion criteria. Results: Forty research papers were related to nursing, and there was only one research paper focused 011 elderly people with CAD. There were no papers using concept analysis, qualitative study. or randomized controlled clinical trial. Almost all definitions of adherence were adopted from outdated compliance definitions with the attribute of 'paternalistic obligation', Measurement tools were not based on theoretical framework of adherence but borrowed from tools for measuring self-care, health behavior, or self-efficacy. Overall patient's adherence was analyzed in most studies, except for a few studies which focused on diet and exercise only. Educational strategy was the main strategy used in intervention studies. Conclusions: The concept of adherence and measurement tools need to be clarified, along with development of the specific adherence interventions according to the type of adherence in patients with CAD.

유전정보 차별금지의 법적문제 - 외국의 규율 동향과 그 시사점을 중심으로 - (Legal and Regulatory Issues in Genetic Information Discrimination - Focusing on Overseas Regulatory Trends and Domestic Implications -)

  • 양지현;김소윤
    • 의료법학
    • /
    • 제18권1호
    • /
    • pp.237-264
    • /
    • 2017
  • 인간게놈프로젝트의 시작과 함께 그 사회적 부작용의 하나로 거론되었던 '유전정보 차별'의 문제가 아직 우리나라에서 크게 부각된 적은 없다. 그러나 2016년 6월 30일부터 시행된 "생명윤리 및 안전에 관한 법률"이 의료기관이 아닌 유전자검사기관의 유전자검사를 예외적으로 허용하자, 국내의 한 보험회사가 신규 암보험 가입자를 대상으로 DTC 유전자 검사를 별도의 무료 서비스로 제공하겠다고 하여 유전자 검사와 관련된 사회적 변화를 실감케 한 바 있다. 정밀의료가 의료의 새로운 표준으로 성큼 다가온 현 시점에서 유전정보 차별에 관한 규율은 더 이상 미룰 수 없는 문제가 되었다. 우리나라는 생명윤리법 제46조, 제67조에서 유전정보를 이유로 한 차별의 금지와 그 위반행위에 대한 벌칙을 규정하고 있지만, 이러한 광범위한 원칙 규정만으로는 보험, 고용 등 구체적인 유전정보 활용 영역에서의 문제점들을 충분히 해결할 수 없다. 미국, 캐나다, 영국, 독일은 상이한 방식으로 유전정보 차별의 문제를 다루고 있다. 미국의 "Genetic Information Non-Discrimination Act"의 경우, 건강보험과 관련된 부분은 기존의 법에 유전정보 차별금지에 관한 내용을 추가하는 형식을 취하고 있다. 또 개인과 그 가족의 유전자 검사 결과 외에 '가족력'까지 포함하여 유전정보의 범위를 매우 넓게 규정하고 있다. 캐나다는 2017년 비교적 최근에 법을 제정하였는데, 보험과 고용 외에 '상품이나 서비스의 거래'에까지 적용범위를 확장하고 있다. 영국은 유전자 검사 중 '개인의 예측적 유전자 검사'에 대해서만 다루고 있는데, 보험의 경우 영국정부와 보험협회의 '협약'을 통해 유전정보의 활용을 2019년까지 유예하는 방식으로 규율하고 있고, 고용의 영역은 ICO가 만든 'Employment Practices Code(2011)'가 기준으로 활용되고 있다. 독일은 유전자 검사에 관한 법 "Gesetz ${\ddot{u}}ber$ genetische Untersuchungen bei Menschen"에서 고용과 보험에서의 유전자 검사 및 그 결과 제출 요구의 원칙적 금지를 규정하고 있다. 이와 같이 각 나라마다 규율형식, 적용범위 뿐만 아니라 규율의 실효성에 대한 평가도 매우 상이하다. 이러한 점에 비추어 보았을 때 우리나라의 유전정보 차별에 관한 규제 역시 관련 규정의 검토, 전문가 집단의 참여 및 이해관계자의 협력을 통해 여러 규제안의 장 단점을 충분히 검증한 후 입법의 단계로 나아가는 것이 바람직할 것이다.

  • PDF